Physician profile
Andreas Wolf
NPI 1073519336
$4,982.91
in general payments reported to CMS, 2019-2025
27 companies · $708 in 2025
The $708 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $995 · 2020: $884 · 2021: $758 · 2022: $716 · 2023: $679 · 2024: $244 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,630.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $733.37 | 2020-2023 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $599.02 | 2019-2025 | Gallant |
| Janssen Pharmaceuticals, INC | $589.66 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $511.02 | 2019-2023 | Farxiga |
| Medtronic, INC. | $476.00 | 2021-2023 | Onyx Frontier |
| Amgen INC. | $444.38 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $316.31 | 2020-2024 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $202.99 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $189.53 | 2019-2025 | |
| Shockwave Medical, INC | $158.68 | 2025 | |
| Pfizer INC. | $124.81 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $98.15 | 2019-2022 | |
| Bridgebio Pharma, INC. | $71.68 | 2025 | Attruby |
| Abiomed | $69.38 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $68.64 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $56.07 | 2024 | Collagenase Santyl |
| Sanofi-Aventis U.S. LLC | $42.87 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $40.82 | 2021 | |
| Teleflex LLC | $35.69 | 2021 | |
| Biotronik INC. | $28.71 | 2025 | Amvia Edge |
| Merit Medical Systems INC | $27.87 | 2025 | Embocath Plus Microcatheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.73 | 2024 | Jardiance |
| Novo Nordisk INC | $16.59 | 2024 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $15.00 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.87 | 2019 | |
| Cardinal Health 200 LLC | $14.78 | 2019 | |
| Medtronic Vascular, INC. | $13.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andreas Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.